# Research Progress on Diseases and Pests of Chrysanthemum (2015–2025)

**Authors:** Yuan Chen, Lihui Han, Tengqing Ye, Chengjian Xie

PMC · DOI: 10.3390/ijms26199767 · 2025-10-07

## TL;DR

This paper reviews recent advances in understanding and managing diseases and pests affecting chrysanthemums from 2015 to 2025.

## Contribution

The paper highlights novel molecular and genomic approaches for pest and disease control in chrysanthemums.

## Key findings

- Molecular techniques like NGS and PCR improved pathogen identification in chrysanthemums.
- Transcription factors WRKY, MYB, and NAC are key in plant resistance mechanisms.
- RNA interference and biocontrol agents show promise for sustainable pest management.

## Abstract

Chrysanthemum morifolium Ramat. is a major ornamental crop that suffers from diverse fungal, bacterial, viral, and insect pests, causing significant yield and quality losses. Between 2015 and 2025, rapid progress in molecular biology, genomics, and ecological regulation has advanced both fundamental research and applied control strategies. Multi-locus sequencing, multiplex PCR, and next-generation sequencing refined the identification of fungal and bacterial pathogens, while functional studies of WRKY, MYB, and NAC transcription factors revealed key resistance modules. Hormone-mediated signaling pathways, particularly those of salicylic acid, jasmonic acid, and abscisic acid, were shown to play central roles in host defense. Despite these advances, durable genetic resistance against bacterial pathogens and broad-spectrum defense against viruses remains limited. Novel technologies, including virus-free propagation, RNA interference, and spray-induced gene silencing, have shown promising outcomes. For insect pests, studies clarified the damage and virus-vectoring roles of aphids and thrips, and resistance traits linked to trichomes, terpenoids, and lignin have been identified. Biocontrol agents such as Trichoderma spp., Bacillus spp., predatory mites, and entomopathogenic fungi have also demonstrated efficacy. Future efforts should integrate molecular breeding, genome editing, RNA-based tools, and microbiome management to achieve sustainable chrysanthemum protection.

## Linked entities

- **Genes:** WRKY (probable WRKY transcription factor 33) [NCBI Gene 103865671], MYB (MYB proto-oncogene, transcription factor) [NCBI Gene 4602], XK (X-linked Kx blood group antigen, Kell and VPS13A binding protein) [NCBI Gene 7504]
- **Chemicals:** salicylic acid (PubChem CID 338), jasmonic acid (PubChem CID 105087), abscisic acid (PubChem CID 30583)

## Full-text entities

- **Chemicals:** salicylic acid (MESH:D020156), terpenoids (MESH:D013729), Biocontrol agents (-), lignin (MESH:D008031), jasmonic acid (MESH:C011006), abscisic acid (MESH:D000040)
- **Species:** Chrysanthemum x morifolium (florist's chrysanthemum, species) [taxon 41568], Thrips (genus) [taxon 45057], Aphidomorpha (aphids, infraorder) [taxon 33380]

---
Source: https://tomesphere.com/paper/PMC12525156